Course Description
| Course | Code | Semester | T+P (Hour) | Credit | ECTS |
|---|---|---|---|---|---|
| PHARMACOLOGY II | - | Fall Semester | 2+0 | 2 | 4 |
| Course Program |
| Prerequisites Courses | |
| Recommended Elective Courses |
| Language of Course | Turkish |
| Course Level | First Cycle (Bachelor's Degree) |
| Course Type | Required |
| Course Coordinator | Assist.Prof. Çağlar MACİT |
| Name of Lecturer(s) | Assist.Prof. Çağlar MACİT, Prof.Dr. Hatice Kübra ELÇİOĞLU |
| Assistant(s) | |
| Aim | To teach the student about autocoids and their importance, Autonomic Nervous System and its drugs, Cardiovascular System diseases and the drugs used in their treatment, and Respiratory system diseases and the drugs used in their treatment. |
| Course Content | This course contains; Introduction to autacoids, histamine and antihistaminics, Endotheline and NO/Arahidonic acid metabolites,Serotonin and Renin-Angiotensin-Kinin ,Introduction to autonomic nervous system and parasympathomimetic drugs,Parasympatholytic drugs,Sympathomimetic drugs and ganglion blockers,Antihypertensive drugs and diuretics I,Antihypertensive drugs and diuretics II,Congestive heart failure and antianginal drugs,Hypolipidemic agents,Anticoagulants and arrhythmics,Antitussives, mucolytics and expectorants,Bronchodilators,Drugs used in electrolite and acid-base imbalance disorders. |
| Dersin Öğrenme Kazanımları | Teaching Methods | Assessment Methods |
| 1. Know the term of autocoid. | 16, 9 | C |
| 1.1. Define histamine and antihistaminics. | 16, 9 | C |
| 1.2. Know the endothelin, Nitric oxide, Arachidonic acid metabolites | 16, 9 | C |
| 1.3. Know the serotonin, renin angiotensin, kinins. | 16, 9 | C |
| 2. Know the autonomic nervous system | 16, 9 | C |
| 2.1. Summarize the pharmacokinetics and pharmacodynamics properties, side effects, contraindications and drug interactions of the autonomic nervous system drugs. | 16, 9 | C |
| 2.2. Interpret the mechanisms of autonomic nervous system drugs. | 16, 9 | C |
| 3. Discuss the pharmacokinetics, pharmacodynamics, side effect profiles and drug interactions of cardiovascular system drugs. | 16, 9 | C |
| 3.1. Interpret the mechanisms of cardiovascular system drugs. | 16, 9 | C |
| 3.2. Give examples to drugs used in cardiovascular system diseases. | 16, 9 | C |
| 4. Discuss the pharmacokinetics, pharmacodynamics, side effect profiles and drug interactions of respiratory system drugs. | 16, 9 | C |
| 4.1. Interpret the mechanisms of respiratory system drugs. | 16, 9 | C |
| 4.2. Give examples to drugs used in respiratory system diseases. | 16, 9 | C |
| Teaching Methods: | 16: Question - Answer Technique, 9: Lecture Method |
| Assessment Methods: | C: Multiple-Choice Exam |
Course Outline
| Order | Subjects | Preliminary Work |
|---|---|---|
| 1 | Introduction to autacoids, histamine and antihistaminics | 1, 2, 3 |
| 2 | Endotheline and NO/Arahidonic acid metabolites | 1, 2, 3 |
| 3 | Serotonin and Renin-Angiotensin-Kinin | 1, 2, 3 |
| 4 | Introduction to autonomic nervous system and parasympathomimetic drugs | 1, 2, 3 |
| 5 | Parasympatholytic drugs | 1, 2, 3 |
| 6 | Sympathomimetic drugs and ganglion blockers | 1, 2, 3 |
| 7 | Antihypertensive drugs and diuretics I | 1, 2, 3 |
| 8 | Antihypertensive drugs and diuretics II | 1, 2, 3 |
| 9 | Congestive heart failure and antianginal drugs | 1, 2, 3 |
| 10 | Hypolipidemic agents | 1, 2, 3 |
| 11 | Anticoagulants and arrhythmics | 1, 2, 3 |
| 12 | Antitussives, mucolytics and expectorants | 1, 2, 3 |
| 13 | Bronchodilators | 1, 2, 3 |
| 14 | Drugs used in electrolite and acid-base imbalance disorders | 1, 2, 3 |
| Resources |
| 1.Kayaalp, SO: Rasyonel Tedavi Yönünden Tıbbi Farmakoloji, Ankara, 2009. 2.Hardman JG, Limbird LE, Eds.: Goodman and Gilman’s The Pharmacological Basis of Therapeutics, New York, 2022. 3.Katzung & Trevor: Farmakoloji, Güneş Kitabevi, 2022.. |
| 1, 2, 3, lecturer notes |
Course Contribution to Program Qualifications
| Course Contribution to Program Qualifications | |||||||
| No | Program Qualification | Contribution Level | |||||
| 1 | 2 | 3 | 4 | 5 | |||
| 1 | PQ-1. Skilfully use information technology to access, follow, evaluate and apply current knowledge in the field of Pharmaceutical Sciences. | X | |||||
| 2 | PQ-2. Have advanced knowledge in APIs and DPs. | X | |||||
| 3 | PQ-3. Collaborate with the experts for collection, interpretation, application and declaration of data in Pharmaceutical Sciences field. | X | |||||
| 4 | PQ-4. Provide best patient counseling services and medication therapy management using his/her knowledge and pharmaceutical information systems to improve the quality of life and safety of patient. | X | |||||
| 5 | PQ-5. Capable of organizing and administering a drugstore as per responsibilities prescribed under the Pharmacy Law, using skills, knowledge and advanced technology systems. | X | |||||
| 6 | PQ-6. Skilfully use computer programs and advanced technology related to the Pharmaceutical Sciences. | X | |||||
| 7 | PQ-7. Provide solutions to the professional issues using scientific knowledge and data. | X | |||||
| 8 | PQ-8. Perform identification, quality control and standardization of the drug products. | X | |||||
| 9 | PQ-9. Prepare and implement developmental plans for his/her subordinates, frequently evaluate their progress and make necessary adjustments. | X | |||||
| 10 | PQ-10. Capable of conducting independent studies with his/her advanced knowledge in pharmaceutical sciences, takes responsibilities in professional organizations and efficiently collaborates with the members of his/her own organization as well as other organizations. | X | |||||
| 11 | PQ-11. Clearly show signs of adoption of life-long learning and openness to further development. | X | |||||
| 12 | PQ-12. Critically evaluate their knowledge in pharmaceutical sciences. | X | |||||
| 13 | PQ-13. Closely follow and evaluate the national and international professional developments. | X | |||||
| 14 | PQ-14. Record and document all professional activities and applications. | X | |||||
| 15 | PQ-15. Communicate all necessary information about medicines to patient, medical personnel and public. | X | |||||
| 16 | PQ-16. Proficient in English to communicate and follow current knowledge in pharmaceutical sciences. | X | |||||
| 17 | PQ-17. Inform officials and organizations about the issues with the quality assurance of pharmaceutical products. | X | |||||
| 18 | PQ-18. Actively involve in the preparation of APIs, every stage of the formulation and production of DPs. | X | |||||
| 19 | PQ-19. Knowledgable in the regulatory rules of new drug application, data protection and patent issues and understand their interrelationship. | X | |||||
| 20 | PQ-20. Have awareness of his/her duties, rights and responsibilities and act based on Pharmacy Law and high professional ethical standards. | X | |||||
| 21 | PQ-21. Familiar with and actively pursue the personal and public health, environmental, and work safety issues. | X | |||||
Assessment Methods
| Contribution Level | Absolute Evaluation | |
| Rate of Midterm Exam to Success | 40 | |
| Rate of Final Exam to Success | 60 | |
| Total | 100 | |
| ECTS / Workload Table | ||||||
| Activities | Number of | Duration(Hour) | Total Workload(Hour) | |||
| Course Hours | 14 | 2 | 28 | |||
| Guided Problem Solving | 14 | 1 | 14 | |||
| Resolution of Homework Problems and Submission as a Report | 0 | 0 | 0 | |||
| Term Project | 0 | 0 | 0 | |||
| Presentation of Project / Seminar | 0 | 0 | 0 | |||
| Quiz | 0 | 0 | 0 | |||
| Midterm Exam | 1 | 31 | 31 | |||
| General Exam | 1 | 36 | 36 | |||
| Performance Task, Maintenance Plan | 0 | 0 | 0 | |||
| Total Workload(Hour) | 109 | |||||
| Dersin AKTS Kredisi = Toplam İş Yükü (Saat)/30*=(109/30) | 4 | |||||
| ECTS of the course: 30 hours of work is counted as 1 ECTS credit. | ||||||
Detail Informations of the Course
Course Description
| Course | Code | Semester | T+P (Hour) | Credit | ECTS |
|---|---|---|---|---|---|
| PHARMACOLOGY II | - | Fall Semester | 2+0 | 2 | 4 |
| Course Program |
| Prerequisites Courses | |
| Recommended Elective Courses |
| Language of Course | Turkish |
| Course Level | First Cycle (Bachelor's Degree) |
| Course Type | Required |
| Course Coordinator | Assist.Prof. Çağlar MACİT |
| Name of Lecturer(s) | Assist.Prof. Çağlar MACİT, Prof.Dr. Hatice Kübra ELÇİOĞLU |
| Assistant(s) | |
| Aim | To teach the student about autocoids and their importance, Autonomic Nervous System and its drugs, Cardiovascular System diseases and the drugs used in their treatment, and Respiratory system diseases and the drugs used in their treatment. |
| Course Content | This course contains; Introduction to autacoids, histamine and antihistaminics, Endotheline and NO/Arahidonic acid metabolites,Serotonin and Renin-Angiotensin-Kinin ,Introduction to autonomic nervous system and parasympathomimetic drugs,Parasympatholytic drugs,Sympathomimetic drugs and ganglion blockers,Antihypertensive drugs and diuretics I,Antihypertensive drugs and diuretics II,Congestive heart failure and antianginal drugs,Hypolipidemic agents,Anticoagulants and arrhythmics,Antitussives, mucolytics and expectorants,Bronchodilators,Drugs used in electrolite and acid-base imbalance disorders. |
| Dersin Öğrenme Kazanımları | Teaching Methods | Assessment Methods |
| 1. Know the term of autocoid. | 16, 9 | C |
| 1.1. Define histamine and antihistaminics. | 16, 9 | C |
| 1.2. Know the endothelin, Nitric oxide, Arachidonic acid metabolites | 16, 9 | C |
| 1.3. Know the serotonin, renin angiotensin, kinins. | 16, 9 | C |
| 2. Know the autonomic nervous system | 16, 9 | C |
| 2.1. Summarize the pharmacokinetics and pharmacodynamics properties, side effects, contraindications and drug interactions of the autonomic nervous system drugs. | 16, 9 | C |
| 2.2. Interpret the mechanisms of autonomic nervous system drugs. | 16, 9 | C |
| 3. Discuss the pharmacokinetics, pharmacodynamics, side effect profiles and drug interactions of cardiovascular system drugs. | 16, 9 | C |
| 3.1. Interpret the mechanisms of cardiovascular system drugs. | 16, 9 | C |
| 3.2. Give examples to drugs used in cardiovascular system diseases. | 16, 9 | C |
| 4. Discuss the pharmacokinetics, pharmacodynamics, side effect profiles and drug interactions of respiratory system drugs. | 16, 9 | C |
| 4.1. Interpret the mechanisms of respiratory system drugs. | 16, 9 | C |
| 4.2. Give examples to drugs used in respiratory system diseases. | 16, 9 | C |
| Teaching Methods: | 16: Question - Answer Technique, 9: Lecture Method |
| Assessment Methods: | C: Multiple-Choice Exam |
Course Outline
| Order | Subjects | Preliminary Work |
|---|---|---|
| 1 | Introduction to autacoids, histamine and antihistaminics | 1, 2, 3 |
| 2 | Endotheline and NO/Arahidonic acid metabolites | 1, 2, 3 |
| 3 | Serotonin and Renin-Angiotensin-Kinin | 1, 2, 3 |
| 4 | Introduction to autonomic nervous system and parasympathomimetic drugs | 1, 2, 3 |
| 5 | Parasympatholytic drugs | 1, 2, 3 |
| 6 | Sympathomimetic drugs and ganglion blockers | 1, 2, 3 |
| 7 | Antihypertensive drugs and diuretics I | 1, 2, 3 |
| 8 | Antihypertensive drugs and diuretics II | 1, 2, 3 |
| 9 | Congestive heart failure and antianginal drugs | 1, 2, 3 |
| 10 | Hypolipidemic agents | 1, 2, 3 |
| 11 | Anticoagulants and arrhythmics | 1, 2, 3 |
| 12 | Antitussives, mucolytics and expectorants | 1, 2, 3 |
| 13 | Bronchodilators | 1, 2, 3 |
| 14 | Drugs used in electrolite and acid-base imbalance disorders | 1, 2, 3 |
| Resources |
| 1.Kayaalp, SO: Rasyonel Tedavi Yönünden Tıbbi Farmakoloji, Ankara, 2009. 2.Hardman JG, Limbird LE, Eds.: Goodman and Gilman’s The Pharmacological Basis of Therapeutics, New York, 2022. 3.Katzung & Trevor: Farmakoloji, Güneş Kitabevi, 2022.. |
| 1, 2, 3, lecturer notes |
Course Contribution to Program Qualifications
| Course Contribution to Program Qualifications | |||||||
| No | Program Qualification | Contribution Level | |||||
| 1 | 2 | 3 | 4 | 5 | |||
| 1 | PQ-1. Skilfully use information technology to access, follow, evaluate and apply current knowledge in the field of Pharmaceutical Sciences. | X | |||||
| 2 | PQ-2. Have advanced knowledge in APIs and DPs. | X | |||||
| 3 | PQ-3. Collaborate with the experts for collection, interpretation, application and declaration of data in Pharmaceutical Sciences field. | X | |||||
| 4 | PQ-4. Provide best patient counseling services and medication therapy management using his/her knowledge and pharmaceutical information systems to improve the quality of life and safety of patient. | X | |||||
| 5 | PQ-5. Capable of organizing and administering a drugstore as per responsibilities prescribed under the Pharmacy Law, using skills, knowledge and advanced technology systems. | X | |||||
| 6 | PQ-6. Skilfully use computer programs and advanced technology related to the Pharmaceutical Sciences. | X | |||||
| 7 | PQ-7. Provide solutions to the professional issues using scientific knowledge and data. | X | |||||
| 8 | PQ-8. Perform identification, quality control and standardization of the drug products. | X | |||||
| 9 | PQ-9. Prepare and implement developmental plans for his/her subordinates, frequently evaluate their progress and make necessary adjustments. | X | |||||
| 10 | PQ-10. Capable of conducting independent studies with his/her advanced knowledge in pharmaceutical sciences, takes responsibilities in professional organizations and efficiently collaborates with the members of his/her own organization as well as other organizations. | X | |||||
| 11 | PQ-11. Clearly show signs of adoption of life-long learning and openness to further development. | X | |||||
| 12 | PQ-12. Critically evaluate their knowledge in pharmaceutical sciences. | X | |||||
| 13 | PQ-13. Closely follow and evaluate the national and international professional developments. | X | |||||
| 14 | PQ-14. Record and document all professional activities and applications. | X | |||||
| 15 | PQ-15. Communicate all necessary information about medicines to patient, medical personnel and public. | X | |||||
| 16 | PQ-16. Proficient in English to communicate and follow current knowledge in pharmaceutical sciences. | X | |||||
| 17 | PQ-17. Inform officials and organizations about the issues with the quality assurance of pharmaceutical products. | X | |||||
| 18 | PQ-18. Actively involve in the preparation of APIs, every stage of the formulation and production of DPs. | X | |||||
| 19 | PQ-19. Knowledgable in the regulatory rules of new drug application, data protection and patent issues and understand their interrelationship. | X | |||||
| 20 | PQ-20. Have awareness of his/her duties, rights and responsibilities and act based on Pharmacy Law and high professional ethical standards. | X | |||||
| 21 | PQ-21. Familiar with and actively pursue the personal and public health, environmental, and work safety issues. | X | |||||
Assessment Methods
| Contribution Level | Absolute Evaluation | |
| Rate of Midterm Exam to Success | 40 | |
| Rate of Final Exam to Success | 60 | |
| Total | 100 | |